相关实验视频

Updated: Jan 16, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

针对FAK,在固体瘤中加强免疫检查点治疗

Karly A Stanley^1,2, Sheri L Holmen^1,2,3

¹Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah 84112, USA.

Journal of cancer immunology

|September 29, 2025

概括

聚焦粘附激酶 (FAK) 抑制剂与免疫检查点抑制剂相结合,可以克服癌症治疗耐药性. 向FAK可以减少免疫抑制并改善免疫细胞功能,以获得更好的癌症治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,但由于耐药性,患者的反应面临挑战.
焦点粘附激酶 (FAK) 通过创建免疫抑制瘤微环境,在癌症进展中发挥作用.
FAK影响血管形成和细胞外基质,阻碍免疫细胞透和药物输送.

研究的目的:

审查FAK如何影响瘤微环境和免疫细胞.
评估结合FAK抑制剂与ICI用于固体瘤治疗的临床潜力.

主要方法:

对FAK在癌症中的作用进行临床前和临床研究的审查.
分析FAK在调节瘤微环境和免疫反应方面的机制.
评估涉及FAK抑制剂和ICI的组合治疗策略.

主要成果:

FAK抑制免疫细胞的招募,刺激和功能有助于免疫逃生.
FAK促进了一个支持瘤的和免疫抑制的微环境.
FAK抑制剂与ICI结合显示出增强抗瘤免疫力的潜力.

结论:

FAK是一种有前途的治疗标,用于克服对免疫检查点抑制的抵抗.
共同准FAK和免疫检查点可能会提高固体瘤的治疗疗效.
需要进一步的临床研究来验证这种组合策略.

关键词:

血管新生的产生.癌症免疫疗法癌症免疫疗法组合疗法是一种组合疗法.纤维化纤维化纤维化焦点粘附激酶的焦点粘附激酶免疫检查点抑制剂免疫检查点抑制剂瘤微环境是一个微环境.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...